If signed into law, S. 2023 would take a number of steps to reduce the cost of prescription drugs, including requiring the Secretary of Health and Human Services to negotiate Part D drug prices, allowing the re-importation of drugs from Canada, closing the "doughnut hole" three years earlier than current law, and prohibiting "pay-for-delay" deals between drug manufacturers.
Sen. Bernie Sanders (VT) introduced S. 2023 on September 10, 2015. It has since been referred to the Committee on Finance.
